Logo
x

Search

Subscribe Now

All Posts by Date

PharmaShots Interview: Janssen’s Soumya D. Chakravarty Shares Insights on Tremfya (guselkumab) for the Treatment of Active Psoriatic Arthritis

PharmaShots Interview: Janssen’s Soumya D. Chakravarty Shares Insights on Tremfya (guselkumab) for the Treatment of Active Psoriat...

  • April 25, 2022
Sol-Gel Technologies and Galderma’ Epsolay Receive the US FDA’s Approval for the Treatment of Inflammatory Lesions of Rosacea in Adults

Sol-Gel Technologies and Galderma’ Epsolay Receive the US FDA’s Approval for the Treatment of Inflammatory Lesions of Rosacea in A...

  • April 25, 2022
Mundipharma and Cidara Present Results of Rezafungin in P-III (ReSTORE) Trial for Treatment of Candidemia or Invasive Candidiasis at ECCMID 2022

Mundipharma and Cidara Present Results of Rezafungin in P-III (ReSTORE) Trial for Treatment of Candidemia or Invasive Candidiasis...

  • April 25, 2022
Shionogi Presents Results of S-217622 in P-IIb Study for the Treatment of COVID-19 at ECCMID 2022

Shionogi Presents Results of S-217622 in P-IIb Study for the Treatment of COVID-19 at ECCMID 2022

  • April 25, 2022
Amryt Receives CHMP Positive Opinion of Filsuvez for the Treatment of Dystrophic and Junctional EB

Amryt Receives CHMP Positive Opinion of Filsuvez for the Treatment of Dystrophic and Junctional EB

  • April 25, 2022
Gilead Presents Results of Veklury (remdesivir) in Multiple Studies for COVID-19 at ECCMIC 2022

Gilead Presents Results of Veklury (remdesivir) in Multiple Studies for COVID-19 at ECCMIC 2022

  • April 25, 2022
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.